Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer

Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer

The treatment of cancer patients has been mainly followed using chemotherapy and it is a gold standard in improving prognosis and survival rate of patients. Oxaliplatin (OXA) is a third-platinum anti-cancer agent that reduces DNA synthesis in cancer cells to interfere with their growth and cell cycl...

Full description

Bibliographic Details
Main Authors: Mehrdad Hashemi, Nastaran Esbati, Mohsen Rashidi, Sadaf Gholami, Rasoul Raesi, Seyed Shahabadin Bidoki, Mohammad Ali Sheikh Beig Goharrizi, Yasamin Sadat Mousavi Motlagh, Ramin Khorrami, Alireza Tavakolpournegari, Noushin Nabavi, Rongjun Zou, Leila Mohammadnahal, Maliheh Entezari, Afshin Taheriazam, Kiavash Hushmandi
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Translational Oncology
Subjects:
Oxaliplatin
Cancer chemotherapy
Drug resistance
Molecular pathways
Colorectal cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523323002322

Internet

http://www.sciencedirect.com/science/article/pii/S1936523323002322

Similar Items